Target intelligence / Profile preview

Ubiquitin-associated domain-containing protein 2 (UBAC2)

Target
UBAC2
Molecular classification
Other (Ubiquitin-associated domain-containing protein)
01

Overview

Ubiquitin-associated domain-containing protein 2 (UBAC2) is an evolutionarily conserved, endoplasmic reticulum (ER)-resident protein characterized by the presence of a ubiquitin-associated (UBA) domain at its C-terminus[1][3][5]. The UBA domain mediates interactions with ubiquitin, implicating UBAC2 in processes coupled to the ubiquitin-proteasome system, such as protein degradation and intracellular protein quality control[2]. In mammalian and plant systems, UBAC2 participates in ER-associated protein degradation (ERAD), modulating the accumulation and stability of specific membrane proteins[1]. In Arabidopsis, UBAC2 regulates copper uptake by stabilizing plasma membrane copper transporters (COPT family), and also participates in pathogen defense by modulating autophagic turnover of ER components and influencing callose deposition at pathogen attack sites[1]. In humans, UBAC2 is involved in negative regulation of canonical Wnt signaling and ER-to-cytosol retrograde protein transport[5]. Despite its defined molecular functions, UBAC2 is not currently considered a therapeutic target, and no drugs are known to interact with it. There are no established biomarkers or specific safety concerns related to UBAC2 modulation. UBAC2 is also referenced as PHGDHL1, among other aliases, and should not be confused with enzymes or membrane receptors. It is classed within a protein family defined by the UBA domain, which is broadly involved in ubiquitin-dependent cellular processes[2].

Other names
PHGDHL1PSEC0110FLJ30548RP11-178C10.1phosphoglycerate dehydrogenase-like protein 1
02

Biological functions

Negative regulation of canonical Wnt signaling pathwayNegative regulation of retrograde protein transport, ER to cytosolER-associated protein degradation (ERAD)Protein trafficking and homeostasis
03

Disease associations

Other (no established direct implication in major human disease categories; reported as genetic risk locus for Behçet’s disease in humans, but not an established therapeutic target)

Beyond the preview

Go deeper on Ubiquitin-associated domain-containing protein 2 (UBAC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-associated domain-containing protein 2 (UBAC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call